CA
PACB icon

CapWealth Advisors’s Pacific Biosciences PACB Stock Holding History

CapWealth Advisors’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-500
Closed -$1K – 456
2013
Q2 		$1K Buy
+500
New +$1.25K ﹤0.01% 420

Other funds holding PACB

MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
RCM
Raging Capital Management Rocky Hill, New Jersey $18.2M AUM 17.75% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

CapWealth Advisors's PACB Position: Q3 2013 in Review

CapWealth Advisors sold out of Pacific Biosciences (PACB) in Q3 2013, closing a stake of 500 shares — an estimated $1K sold.

CapWealth Advisors first reported a position in PACB in Q2 2013 and held it in 1 quarter. The position peaked at $1K in Q2 2013. 81 funds tracked by Wall St. Rank hold PACB as of Q3 2013.

  • CapWealth Advisors reported no remaining Pacific Biosciences position as of Q3 2013 after selling out during the quarter.
  • CapWealth Advisors sold 500 Pacific Biosciences shares in Q3 2013, an estimated $1K.
  • CapWealth Advisors first reported a position in Pacific Biosciences in Q2 2013 and held it in 1 quarter.
  • CapWealth Advisors's Pacific Biosciences position peaked at $1K in Q2 2013.
  • 81 funds tracked by Wall St. Rank held Pacific Biosciences as of Q3 2013.

Based on CapWealth Advisors's 13F filing for Q3 2013, filed 13 Nov 2013.